You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nivolumab

Showing 26 - 50 of 806
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Amsterdam (Irreversible Electroporation (IRE), Nivolumab, Toll-Like

Recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Irreversible Electroporation (IRE)
  • +2 more
  • Amsterdam, North-Holland, Netherlands
    Amsterdam University Medical Centre (location VUmc)
Dec 18, 2022

Metastatic Pancreatic Cancer Trial in Bern, Basel, Zürich (Nivolumab)

Recruiting
  • Metastatic Pancreatic Cancer
  • Nivolumab
  • Bern, BE, Switzerland
  • +2 more
Nov 15, 2022

Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

Recruiting
  • Non-Clear Cell Renal Cell Carcinoma
  • Duarte, California
    Exelixis Clinical Site #1
Jan 13, 2023

Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,

Not yet recruiting
  • Metastatic Extraskeletal Myxoid Chondrosarcoma
  • +3 more
  • Biopsy
  • +6 more
  • (no location specified)
Apr 25, 2023

Ovarian Cancer Trial in Houston (Nivolumab, Etigilimab)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Muscle-Invasive Bladder Carcinoma, Bladder Cancer Trial in Tampa (CG0070, Nivolumab)

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Bladder Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Nov 11, 2022

Metastatic Breast Cancer, Brain Metastases Trial in Tampa (Nivolumab, Stereotactic Radiosurgery)

Active, not recruiting
  • Metastatic Breast Cancer
  • Brain Metastases
  • Nivolumab
  • Stereotactic Radiosurgery
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 17, 2022

NSCLC Trial in Worldwide (BMS-986315, Nivolumab, Pemetrexed)

Not yet recruiting
  • NSCLC
  • Boise, Idaho
  • +12 more
Oct 17, 2023

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)

Recruiting
  • Stage III Non-small-cell Lung Cancer
  • Neoadjuvant therapy
  • +4 more
  • Foshan, Guangdong, China
  • +2 more
Oct 25, 2022

Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • Lung Cancer Stage III
  • Nivolumab and Chemotherapy
  • +3 more
  • (no location specified)
Aug 15, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Adenosine A2B Receptor Antagonist PBF-1129
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 1, 2023

CNS B-Cell Non-Hodgkin Lymphoma, Recurrent CNS Lymphoma, Refractory CNS Lymphoma Trial in Houston (Ibrutinib, Nivolumab)

Recruiting
  • Central Nervous System B-Cell Non-Hodgkin Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Nivolumab
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

Melanoma Trial in Tampa (CC-122, Nivolumab)

Completed
Has Results
  • Melanoma
  • Tampa, Florida
    H Lee Moffitt Cancer Center and Research Institute
Sep 27, 2022

Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Metastatic Cancer
  • (no location specified)
Aug 12, 2022

Non Small Cell Lung Cancer Trial in Providence (Ipilimumab, Nivolumab, SBRT)

Recruiting
  • Non Small Cell Lung Cancer
  • Providence, Rhode Island
    Rhode Island Hospital
Jan 26, 2023

Colorectal Cancer Liver Metastases Trial (CapOx(Capecitabine+ Oxaliplatin), Bevacizumab, Nivolumab)

Not yet recruiting
  • Colorectal Cancer Liver Metastases
  • CapOx(Capecitabine+ Oxaliplatin)
  • +2 more
  • (no location specified)
Oct 18, 2022

Oropharynx Squamous Cell Carcinoma Trial in Ann Arbor (Nivolumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Oropharynx Squamous Cell Carcinoma
  • Nivolumab
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 20, 2022

Breast Cancer Trial in Boston, Pittsburgh, Dallas (Nivolumab, Ipilimumab)

Active, not recruiting
Has Results
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
Oct 21, 2022

Head Neck Cancer Trial in Houston (Nivolumab)

Recruiting
  • Head and Neck Cancer
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 13, 2022

Multiple Myeloma Trial in Boston (Nivolumab, DC/myeloma fusions/GM-CSF)

Terminated
Has Results
  • Multiple Myeloma
  • Nivolumab
  • DC/myeloma fusions/GM-CSF
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Sep 28, 2022

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

Not yet recruiting
  • Metastatic Nasopharyngeal Carcinoma
  • +2 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Jun 13, 2023

Leukoplakia, Oral Trial in Boston (Nivolumab)

Active, not recruiting
  • Leukoplakia, Oral
  • Nivolumab
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 19, 2022

Mucinous Tumor, Colorectal Tumor, Appendiceal Tumor Trial in Philadelphia (Nivolumab, Ipilimumab)

Terminated
Has Results
  • Mucinous Adenocarcinoma of the Colon
  • Mucinous Adenocarcinoma of the Rectum
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Sep 26, 2022